Conservative Ad Blitz Urges GOP Opposition to 340B, Praises Virginia Governor’s Drug Industry-Friendly Amendment

Building America's Future, a conservative nonprofit, is running an ad campaign asking states to "follow Youngkin's lead" and reject 340B legislation.
After Virginia Gov. Glenn Youngkin (R) amended a bill to delay legislation prohibiting certain drugmaker 340B contract pharmacy restrictions in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Adds Cancer Drug to Contract Pharmacy Restriction Policy

Drug manufacturer AbbVie recently added a cancer medication to its 340B contract pharmacy restrictions for hospitals.
Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sectyr

Q: Tell us some interesting details about your company’s history.

Sectyr was founded to achieve the goal of helping our customers with Continuous Program Compliance. While we have many customers

Read More »

CPS

Q: Tell us some interesting details about your company’s history.

At CPS Solutions, LLC. (CPS), we’ve been partnering with healthcare organizations to transform pharmacy results for over 50 years.

In

Read More »
Industry Insights Logo

Key Considerations for the SUSTAIN 340B Act

SPONSORED CONTENT

On February 2, six senators known as the “Gang of Six” – John Thune, Debbie Stabenow, Shelley Moore Capito, Tammy Baldwin, Jerry Moran and Ben Cardin – unveiled a discussion draft bill intended to preserve the 340B program and codify in statute

Read More »
Industry Insights Logo

Visante’s Top 10 Issues Facing Health System Pharmacy for 2024

SPONSORED CONTENT

 In 2024, pharmacy will play an even more significant and critical role in health systems’ financial and operational performance nationwide. While health systems face daunting challenges, increasing risks, and suffocating regulatory and compliance burdens, high-performing pharmacy organizations

Read More »

Top 10 Most Read 340B Report Articles in 2023

Top 10 graphic image
These are top 10 most read 340B Report articles for 2023.
Among the many tumultuous developments affecting the 340B discount drug program in 2023, the most popular news articles in 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

A Tribute to Our Founding Editor in Chief from the Publisher and CEO

Ted Slafsky, publisher and CEO of 340B Report, calls retiring editor-in-chief Tom Mirga a "brilliant writer and reporter" in a tribute editorial.
When I thought about launching 340B Report, the first person I reached out to was Tom Mirga. Tom and I [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

4 Ways Hospital Pharmacies Can Unlock Financial Stability

SPONSORED CONTENT

With so many challenges facing health systems today — from 340B contract pharmacy restrictions to drug shortages, labor issues, and ever-rising costs — revenue integrity has become essential to financial stability.

With huge increases in drug expenditures from pre-pandemic levels, health systems must

Read More »
Industry Insights Logo

5 Best Practices for Running and Optimizing a Mixed-Use Program

SPONSORED CONTENT

To ensure compliance, maximize savings, and streamline operations, consider these five best practices.

1. Proficiency in Data Management

To effectively manage your 340B program, it’s crucial to comprehend how data is created, stored, and transmitted to your Third-Party Administrator (TPA). Typically,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live